Peter Hohenstein

Peter Hohenstein

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VVVeronique Vitart
Veronique Vitart
IRIgor Rudan
Igor Rudan
CHCaroline Hayward
Caroline Hayward
NGNicola K Gray
Nicola K Gray
JFJames Floyd
James Floyd
AWAlan F Wright
Alan F Wright

20 December 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
OMOfelia M Martínez-Estrada
Ofelia M Martínez-Estrada
LLLaura A Lettice
Laura A Lettice
AEAbdelkader Essafi
Abdelkader Essafi
JGJuan Antonio Guadix
Juan Antonio Guadix
JSJoan Slight
Joan Slight
NHNicholas D Hastie
Nicholas D Hastie
Nicholas Hastie and colleagues show that Wt1 is required for the epithelial-to-mesenchymal (EMT) transition in the developing epicardium and the formation of mesenchymal cardiovascular progenitors. Wt1 directly regulates the transcription of Snail and E-cadherin, two well-known mediators of EMT. The epicardial epithelial-mesenchymal transition (EMT) is hypothesized to generate cardiovascular progenitor cells that differentiate into various cell types, including coronary smooth muscle and endothelial cells, perivascular and cardiac interstitial fibroblasts and cardiomyocytes. Here we show that an epicardial-specific knockout of the gene encoding Wilms' tumor-1 (Wt1) leads to a reduction in mesenchymal progenitor cells and their derivatives. We show that Wt1 is essential for repression of the epithelial phenotype in epicardial cells and during embryonic stem cell differentiation through direct transcriptional regulation of the genes encoding Snail (Snai1) and E-cadherin (Cdh1), two of the major mediators of EMT. Some mesodermal lineages do not form in Wt1-null embryoid bodies, but this effect is rescued by the expression of Snai1, underscoring the importance of EMT in generating these differentiated cells. These new insights into the molecular mechanisms regulating cardiovascular progenitor cells and EMT will shed light on the pathogenesis of heart diseases and may help the development of cell-based therapies.

15 October 2006 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
PHPeter Hohenstein
Peter Hohenstein
NHNicholas D. Hastie
Nicholas D. Hastie
Over the years, many apparently contradictory findings and functions have been ascribed to the protein product of the WT1 tumour suppressor gene. These include being a transcriptional activator or repressor, a function in transcription versus RNA metabolism, and these days even a function as oncogene or tumour suppressor gene. To fully understand the role of WT1 in different diseases and normal development, we will need to understand these contradictions. In this review, we will discuss the present state of knowledge and suggest that a role for WT1 in influencing the mesenchymal–epithelial state of cells might be a common function that could explain many of the previously described findings.

3 March 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Thomas WishartThomas Wishart
Thomas Wishart
CMChantal A. Mutsaers
Chantal A. Mutsaers
Markus RiesslandMarkus Riessland
Markus Riessland
MRMichell M. Reimer
Michell M. Reimer
GHGillian Hunter
Gillian Hunter
TGThomas Gillingwater
Thomas Gillingwater
The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development. Here, we determined that ubiquitin-dependent pathways regulate neuromuscular pathology in SMA. Using mouse models of SMA, we observed widespread perturbations in ubiquitin homeostasis, including reduced levels of ubiquitin-like modifier activating enzyme 1 (UBA1). SMN physically interacted with UBA1 in neurons, and disruption of Uba1 mRNA splicing was observed in the spinal cords of SMA mice exhibiting disease symptoms. Pharmacological or genetic suppression of UBA1 was sufficient to recapitulate an SMA-like neuromuscular pathology in zebrafish, suggesting that UBA1 directly contributes to disease pathogenesis. Dysregulation of UBA1 and subsequent ubiquitination pathways led to β-catenin accumulation, and pharmacological inhibition of β-catenin robustly ameliorated neuromuscular pathology in zebrafish, Drosophila, and mouse models of SMA. UBA1-associated disruption of β-catenin was restricted to the neuromuscular system in SMA mice; therefore, pharmacological inhibition of β-catenin in these animals failed to prevent systemic pathology in peripheral tissues and organs, indicating fundamental molecular differences between neuromuscular and systemic SMA pathology. Our data indicate that SMA-associated reduction of UBA1 contributes to neuromuscular pathogenesis through disruption of ubiquitin homeostasis and subsequent β-catenin signaling, highlighting ubiquitin homeostasis and β-catenin as potential therapeutic targets for SMA.

1 September 2011 in Developmental Cell
Verified
Journal Article
Closed access
AEAbdelkader Essafi
Abdelkader Essafi
AWAnna Webb
Anna Webb
RBRachel L. Berry
Rachel L. Berry
JSJoan Slight
Joan Slight
SBSally F. Burn
Sally F. Burn
PHPeter Hohenstein
Peter Hohenstein

25 November 2003 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JDJamie A. Davies
Jamie A. Davies
MLMichael Ladomery
Michael Ladomery
PHPeter Hohenstein
Peter Hohenstein
LMLydia Michael
Lydia Michael
ASAnna Shafe
Anna Shafe
NHNick Hastie
Nick Hastie
Wt1 is a tumour suppressor gene, mutation of which is a cause of Wilms' tumour, a childhood renal nephroblastoma. Wt1 is expressed in a rich pattern during renal development suggesting that it acts at three stages: determination of the kidney area, the differentiation of nephrons and maturation of glomeruli. Wt1−/− mice confirm that Wt1 is essential for the inception of kidney development; cells that ought to form kidneys die by apoptosis instead. Specific human WT1 mutations cause defects of glomerular maturation (Denys–Drash and Frasier syndromes), providing circumstantial evidence for action of Wt1 during glomerular maturation. There is, however, no genetic evidence for a function during nephron differentiation because this stage is never reached in Wt1−/− mice. We have therefore developed a novel technique, based on small interfering RNA (siRNA), to repress the expression of Wt1 and other specific genes at different stages of kidney development in culture. We find that early repression of Wt1 phenocopies the Wt1−/− mouse, but later repression prevents cells differentiating into nephrons and causes them instead to proliferate abnormally, possibly mimicking aspects of Wilms' tumour. In line with established hypotheses about genetic pathways that control kidney development, we find that repressing Pax2 using siRNAs represses Wt1 expression and blocks both bud growth and nephron differentiation, but that repressing Wnt4 blocks nephron differentiation without affecting Wt1 expression. As well as illuminating previously inaccessible aspects of Wt1 biology, our results suggest that siRNA in organ culture will be a powerful method for analyzing other developmental pathways and testing the effects of stage-specific loss of tumour suppressor genes.